CSMD3 (CUB and sushi multiple domains 3), also known as CRIM1L (cysteine-rich transmembrane BMP regulator 1-like protein), is a transmembrane protein predominantly expressed in neuronal tissues, where it plays integral roles in orchestrating diverse cellular processes critical for proper neural development and function. Within neuronal contexts, CSMD3 functions as a modulator of cell adhesion, migration, and intracellular signaling, exerting regulatory control over synaptic plasticity and neuronal connectivity. Through its interactions with various signaling pathways, including the Wnt, PI3K/Akt, and MAPK pathways, CSMD3 serves as a key mediator of intracellular communication, influencing gene expression, cell survival, and neuronal differentiation.
Activation of CSMD3 involves intricate modulation of its associated signaling cascades, leading to enhanced protein expression and functional activity. Mechanistically, activation of CSMD3 can occur through stimulation of upstream signaling pathways that converge on its regulatory networks. For instance, activation of the Wnt signaling pathway, a crucial regulator of neuronal development, can lead to increased expression and function of CSMD3 through transcriptional activation of its gene. Similarly, activation of the PI3K/Akt pathway, which governs cell survival and growth, may promote CSMD3 activity by facilitating its post-translational modifications or subcellular localization. Furthermore, activation of the MAPK pathway, involved in cellular proliferation and differentiation, could indirectly enhance CSMD3 expression and function through modulation of downstream effectors. Overall, the activation of CSMD3 represents a tightly regulated process orchestrated by the convergence of multiple signaling pathways, highlighting its pivotal role in mediating neuronal development and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to modulate immune responses and cellular signaling pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects various signaling pathways, potentially impacting immune response and cancer-related processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A chemotherapeutic agent that can influence cell signaling and immune responses. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Disrupts microtubule function and can affect cellular processes including those related to immune response. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that modulates several cellular pathways, potentially affecting CSMD3-related pathways. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates cytokine production and immune response, potentially impacting CSMD3. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, known to influence immune response and cancer pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A kinase inhibitor with potential effects on immune modulation and cancer pathways. | ||||||